InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

AETHLON MEDICAL INC

AEMD Clue Score37
United States Fiscal year ends March CIK 0000882291
$6.05 +0.67% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $6.05 +77.94% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue0.4Operating income−6.1Net income−7.3Fiscal year 2018Revenue0.1 −61.8%Operating income−4.8Net income−5.7Fiscal year 2019Revenue0.2 +53.5%Operating income−6.0Net income−6.2Fiscal year 2020Revenue0.7 +183.2%Operating income−5.9Net income−6.4Fiscal year 2021Revenue0.7 +1.4%Operating income−7.9Net income−7.9Fiscal year 2022Revenue0.3 −55.4%Operating income−10.4Net income−10.4EPS, diluted−0.71Fiscal year 2023Revenue0.6 +95.2%Operating income−11.9Net income−12.0EPS, diluted−5.86Fiscal year 2024Revenue0.0 −100.0%Operating income−12.6Net income−12.2EPS, diluted−38.87Fiscal year 2025Operating income−9.3Net income−13.4EPS, diluted−85.77Fiscal year 2026Operating income−7.3Net income−7.2EPS, diluted−10.61
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 0.4 0.1 0.2 0.7 0.7 0.3 0.6 0.0 n/a n/a
Growth −61.8% +53.5% +183.2% +1.4% −55.4% +95.2% −100.0%
Operating income −6.1 −4.8 −6.0 −5.9 −7.9 −10.4 −11.9 −12.6 −9.3 −7.3
Net income −7.3 −5.7 −6.2 −6.4 −7.9 −10.4 −12.0 −12.2 −13.4 −7.2
Growth
EPS, diluted n/a n/a n/a n/a n/a −0.71 −5.86 −38.87 −85.77 −10.61

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−1,555.4%Net margin−1,855.8%Free cash flow margin−898.4%Fiscal year 2018Operating margin−3,228.8%Net margin−3,795.9%Free cash flow margin−2,630.2%Fiscal year 2019Operating margin−2,612.5%Net margin−2,697.8%Free cash flow margin−1,869.8%Fiscal year 2020Operating margin−912.0%Net margin−980.3%Free cash flow margin−822.7%Fiscal year 2021Operating margin−1,197.3%Net margin−1,196.6%Free cash flow margin−1,035.5%Fiscal year 2022Operating margin−3,542.5%Net margin−3,540.9%Free cash flow margin−3,439.0%Fiscal year 2023Operating margin−2,072.0%Net margin−2,094.9%Free cash flow margin−1,993.6%Fiscal year 2024Fiscal year 2025Fiscal year 2026
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating margin −1,555.4% −3,228.8% −2,612.5% −912.0% −1,197.3% −3,542.5% −2,072.0% n/a n/a n/a
Net margin −1,855.8% −3,795.9% −2,697.8% −980.3% −1,196.6% −3,540.9% −2,094.9% n/a n/a n/a
Free cash flow margin −898.4% −2,630.2% −1,869.8% −822.7% −1,035.5% −3,439.0% −1,993.6% n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−3.5Capital expenditure−0.0Free cash flow−3.5Fiscal year 2018Operating cash flow−3.9Capital expenditure−0.0Free cash flow−3.9Fiscal year 2019Operating cash flow−4.3Capital expenditure0.0Free cash flow−4.3Fiscal year 2020Operating cash flow−5.2Capital expenditure−0.2Free cash flow−5.3Fiscal year 2021Operating cash flow−6.8Capital expenditure−0.1Free cash flow−6.8Fiscal year 2022Operating cash flow−9.8Capital expenditure−0.3Free cash flow−10.1Fiscal year 2023Operating cash flow−10.5Capital expenditure−0.9Free cash flow−11.4Fiscal year 2024Operating cash flow−10.1Capital expenditure−0.3Free cash flow−10.4Fiscal year 2025Operating cash flow−7.6Capital expenditure0.0Free cash flow−7.6Fiscal year 2026Operating cash flow−7.0Capital expenditure−0.0Free cash flow−7.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −3.5 −3.9 −4.3 −5.2 −6.8 −9.8 −10.5 −10.1 −7.6 −7.0
Capital expenditure −0.0 −0.0 0.0 −0.2 −0.1 −0.3 −0.9 −0.3 0.0 −0.0
Free cash flow −3.5 −3.9 −4.3 −5.3 −6.8 −10.1 −11.4 −10.4 −7.6 −7.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Shareholders’ equity0.7Fiscal year 2018Shareholders’ equity6.1Fiscal year 2019Cash3.8Shareholders’ equity2.4Fiscal year 2020Cash9.6Shareholders’ equity9.4Fiscal year 2021Cash9.9Shareholders’ equity9.4Fiscal year 2022Cash17.1Shareholders’ equity17.0Fiscal year 2023Cash14.5Shareholders’ equity15.1Fiscal year 2024Cash5.4Shareholders’ equity5.8Fiscal year 2025Cash5.5Shareholders’ equity5.1Fiscal year 2026Cash5.0Shareholders’ equity4.9
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash n/a n/a 3.8 9.6 9.9 17.1 14.5 5.4 5.5 5.0
Shareholders’ equity 0.7 6.1 2.4 9.4 9.4 17.0 15.1 5.8 5.1 4.9

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Mar 2017 FY2018 31 Mar 2018 FY2019 31 Mar 2019 FY2020 31 Mar 2020 FY2021 31 Mar 2021 FY2022 31 Mar 2022 FY2023 31 Mar 2023 FY2024 31 Mar 2024 FY2025 31 Mar 2025 FY2026 31 Mar 2026
Margins
−1,555.4% −3,228.8% −2,612.5% −912.0% −1,197.3% −3,542.5% −2,072.0% n/a n/a n/a
−1,855.8% −3,795.9% −2,697.8% −980.3% −1,196.6% −3,540.9% −2,094.9% n/a n/a n/a
−898.4% −2,630.2% −1,869.8% −822.7% −1,035.5% −3,439.0% −1,993.6% n/a n/a n/a
Spending
171.7% 391.6% 390.2% 142.6% 314.4% 795.8% 478.0% n/a n/a n/a
216.7% 529.7% 415.2% 238.2% 372.9% 1,174.6% 780.4% n/a n/a n/a
4.2% 16.6% 0.0% 23.3% 9.1% 118.7% 164.2% n/a n/a n/a
Returns
−1,075.7% −92.6% −255.4% −67.7% −83.6% −61.3% −79.9% −211.7% −261.3% −146.4%
−421.5% −77.3% −150.2% −61.4% −73.9% −53.6% −68.7% −148.0% −181.9% −112.9%
Balance and payout
65.5% 17.9% 44.2% 10.7% 12.9% 12.5% 14.0% 30.1% 30.4% 22.8%